Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.49 +0.11 (+0.51%)
As of: Nov 16, 2026 · 9:46 AM EST

Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded Restructuring Costs of $936,000 in Q3 2026, up 554.5% from $143,000 a year earlier but down 87.7% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026) Analysis & Trends

On a TTM basis, Amneal Pharmaceuticals' Restructuring Costs came in at $16.16 million as of Sep 30, 2026, up 624.3% year-over-year; for FY2025, it came in at $4.21 million, up 78.7% from FY2024.

  • Annual Restructuring Costs has increased for three straight years, though with a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
  • Across earlier years, Restructuring Costs came in at $2.36 million in FY2024 (+34.6%), $1.75 million in FY2023 (+23.1%), $1.42 million in FY2022 (-82.5%) and $8.1 million in FY2021 (-10.0%).
  • Quarterly Restructuring Costs has ranged from $82,000 in Q2 2023 to $7.6 million in Q2 2026 over the past five years.
  • On a year-over-year basis, Restructuring Costs has increased for four consecutive quarters, with growth averaging 377.5% over the last eight quarters.
  • Peak year-over-year performance for Restructuring Costs in the last five years was growth of 802.5% in Q1 2026, against a decline of 98.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $7.6 million (Q2 2026), $5.15 million (Q1 2026) and $2.47 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,305.71 Bn 1,279.33 Bn 20.46 Bn
2 Johnson & Johnson 694.23 Bn 614.09 Bn 17.30 Bn
3 AbbVie 528.96 Bn 496.97 Bn 13.12 Bn
4 Merck 365.92 Bn 328.86 Bn 13.19 Bn
5 Novartis Ag 314.95 Bn 288.19 Bn -
6 Astrazeneca 289.15 Bn 262.67 Bn 13.26 Bn
7 Amgen 254.11 Bn 205.76 Bn 7.58 Bn
8 Gilead Sciences 211.85 Bn 186.96 Bn 6.73 Bn
9 Pfizer 165.73 Bn 113.09 Bn 12.56 Bn
10 Amneal Pharmaceuticals 7.21 Bn 6.44 Bn 334.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 936,000.00
Jun 30, 2026 7.60 Mn
Mar 31, 2026 5.15 Mn
Dec 31, 2025 2.47 Mn
Sep 30, 2025 143,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 571,000.00
Dec 31, 2024 493,000.00
Sep 30, 2024 172,000.00
Jun 30, 2024 220,000.00
Mar 31, 2024 1.47 Mn
Dec 31, 2023 114,000.00
Sep 30, 2023 1.04 Mn
Jun 30, 2023 82,000.00
Mar 31, 2023 510,000.00
Dec 31, 2022 109,000.00
Sep 30, 2022 581,000.00
Mar 31, 2022 731,000.00
Dec 31, 2021 7.31 Mn
Sep 30, 2021 425,000.00
API Access

Amneal Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AMRX&period=max&api_key=YOUR_API_KEY